Trend Results : Cancer Center


Related Searches

Blog Post Results (1-20 of 4980)

FILTER RESULTS

Skin cancer treatment selfie goes viral, has public health lessons

(UNC Lineberger Comprehensive Cancer Center) In a new study, researchers analyzed the impact of one viral social media post in generating awareness about skin cancer.

The quackery of “naturopathic oncology” is metastasizing

"Integrating" naturopathic care with real medicine started out largely in academic medical centers. Unfortunately, the cancer of integrative oncology appears to be metastasizing to community hospitals. The post The quackery of “naturopathic oncology” is metastasizing appeared first on RESPECTFUL INSOLENCE.

Pediatric Cancer Providers Give Medical Marijuana a Cautious Thumbs-Up

New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are more cautious than those who aren't.

Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy

(Ohio State University Wexner Medical Center) A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics specifically to cancer cells. Researchers used RNA nanotechnology to apply the RNA nanoparticles and control their orientation. Show More Summary

Immunotherapy strategy could be beneficial for relapsed acute myeloid leukemia

ATLANTA - University of North Carolina Lineberger Comprehensive Cancer Center researchers report that pairing an immunotherapy drug with chemotherapy proved beneficial for some patients with acute myeloid leukemia whose disease did not respond to standard treatment or had relapsed.

Report: New System for More Accurate Cancer Staging to Aid Precision Medicine

Adding a blood test called liquid biopsy to a standard tissue biopsy could significantly improve the accuracy of diagnosis and treatment for patients with cancer, according to researchers at Wake Forest Baptist Medical Center.

AML study reports high response rates with combination targeted therapy

(University of Texas M. D. Anderson Cancer Center) Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent patients say researchers at The University of Texas MD Anderson Cancer Center.

Report: New system for more accurate cancer staging to aid precision medicine

(Wake Forest Baptist Medical Center) Adding a blood test called liquid biopsy to a standard tissue biopsy could significantly improve the accuracy of diagnosis and treatment for patients with cancer, according to researchers at Wake Forest Baptist Medical Center.

Using software, researchers predict tumor markers that could be immune targets

(UNC Lineberger Comprehensive Cancer Center) Researchers report at the 59th Annual American Society for Hematology Annual Meeting in Atlanta on Saturday, Dec. 9, that they were able to validate their approach for predicting markers - called minor histocompatibility antigens - in a group of patients with blood cancers.

Immunotherapy strategy could be beneficial for relapsed acute myeloid leukemia

(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers will present preliminary results from an ongoing phase II trial of chemotherapy and pembrolizumab in relapsed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta on Saturday, Dec. 9.

Use of chemotherapy for early stage breast cancer declines, Stanford-led study says

(Stanford University Medical Center) A study of nearly 3,000 women with early stage breast cancer indicates a recent, significant decline in the use of chemotherapy despite the lack of any change in national treatment recommendations or guidelines, according to researchers at the Stanford University School of Medicine and the University of Michigan.

Soy, cruciferous vegetables associated with fewer common breast cancer treatment side effects

(Georgetown University Medical Center) Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, say a team of scientists.

Landmark CAR-T cancer study published in the New England Journal of Medicine

MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells. Patrick...Show More Summary

Phase 2 CAR-T study reports significant remission rates at 15-month follow up

(University of Texas M. D. Anderson Cancer Center) A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows that 42 percent of patients with aggressive large B-cell lymphoma remained in remission at 15 months following treatment with axi-cel (marketed as Yescarta?).

Landmark CAR-T Cancer Study Published in the New England Journal of Medicine

Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

For women with genetic risk, bi-annual MRI beats mammograms

(University of Chicago Medical Center) Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram. Show More Summary

PARP Inhibitor Improves Progression-Free Survival in Patients with Advanced Breast Cancers and BRCA Mutations

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA

(University of Texas M. D. Anderson Cancer Center) In a randomized, Phase III trial led by researchers at the University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) andShow More Summary

A common virus may help inform treatment planning for stem cell transplant patients

(Virginia Commonwealth University) a team of scientists from VCU Massey Cancer Center have shown a genetic relationship between the reactivation of the human cytomegalovirus and the onset of graft-versus-host disease (GVHD), a potentially deadly condition in which the immune system attacks healthy tissue following a bone marrow or stem cell transplant.

Biological factors don't fully explain racial disparities for breast cancer type

(UNC Lineberger Comprehensive Cancer Center) The biological features of patients' tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger Comprehensive Cancer Center researchers said it didn't explain it completely. Show More Summary

Copyright © 2015 Regator, LLC